Avidity Partners Management LP
45 holdingsFiling period: 2026-06-30Current AUM: $512.9Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | DNTH | Dianthus Therapeutics Inc | 2.10M | $205.1M | $166.9M | 32.55% | -- | 2026-06-30 |
| 2 | CGON | CG Oncology Inc | 1.40M | $99.4M | $86.1M | 16.79% | -- | 2026-06-30 |
| 3 | ORKA | Oruka Therapeutics Inc | 760.4K | $72.4M | $68.7M | 13.39% | -- | 2026-06-30 |
| 4 | JBIO | Jade Biosciences Inc | 1.70M | $37.8M | $24.7M | 4.81% | +300.0K | 2026-06-30 |
| 5 | ELVN | Enliven Therapeutics Inc | 550.0K | $27.9M | $22.8M | 4.45% | +150.0K | 2026-06-30 |
| 6 | CATX | Perspective Therapeutics Inc | 6.30M | $21.5M | $7.6M | 1.49% | +250.0K | 2026-06-30 |
| 7 | AKTS | Aktis Oncology Inc | 484.2K | $15.6M | $7.6M | 1.48% | +15.6K | 2026-06-30 |
| 8 | PVLA | Palvella Therapeutics Inc NE | 70.0K | $10.7M | $8.8M | 1.72% | -- | 2026-06-30 |
| 9 | MOBI | Mobia Med Inc | 798.3K | $10.7M | $8.6M | 1.67% | -- | 2026-06-30 |
| 10 | RGEN | Repligen Corp | 77.8K | $10.6M | $14.0M | 2.73% | -- | 2026-06-30 |
| 11 | IMUX | Immunic Inc | 669.9K | $10.3M | $4.9M | 0.95% | -- | 2026-06-30 |
| 12 | SENS | Senseonics Hldgs Inc | 1.60M | $9.1M | $12.0M | 2.33% | -- | 2026-06-30 |
| 13 | KPTI | Karyopharm Therapeutics Inc | 924.5K | $9.0M | $446K | 0.09% | +460.7K | 2026-06-30 |
| 14 | TEVA | Teva Pharmaceutical Inds Ltd | 200.0K | $6.8M | $8.0M | 1.56% | -- | 2026-06-30 |
| 15 | DXCM | Dexcom Inc | 100.0K | $6.7M | $7.9M | 1.53% | -- | 2026-06-30 |
| 16 | TEM | Tempus AI Inc | 105.0K | $6.1M | $7.1M | 1.37% | +40.0K | 2026-06-30 |
| 17 | — | Medtronic PLC | 70.0K | $5.5M | $5.5M | 1.07% | -30,000 | 2026-06-30 |
| 18 | VIR | Vir Biotechnology Inc | 519.3K | $5.3M | $5.7M | 1.12% | -100,000 | 2026-06-30 |
| 19 | GPCR | Structure Therapeutics Inc | 98.0K | $5.3M | $2.1M | 0.40% | +50.0K | 2026-06-30 |
| 20 | EHC | Encompass Health Corp | 42.0K | $4.2M | $5.2M | 1.02% | -- | 2026-06-30 |
| 21 | TENX | Tenax Therapeutics Inc | 265.9K | $3.9M | $436K | 0.09% | -- | 2026-06-30 |
| 22 | NVCT | Nuvectis Pharma Inc | 200.0K | $3.7M | $3.7M | 0.72% | -- | 2026-06-30 |
| 23 | PODD | Insulet Corp | 24.0K | $3.7M | $3.6M | 0.70% | +14.0K | 2026-06-30 |
| 24 | BSX | Boston Scientific Corp | 80.0K | $3.4M | $3.6M | 0.71% | +20.0K | 2026-06-30 |
| 25 | MSLE | Satellos Bioscience Inc | 387.8K | $3.0M | $2.5M | 0.49% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2